Navigation Links
The wonders of wine
Date:9/17/2009

Two years ago, a group of friends were enjoying a glass of wine in the Mosel region in south-west Germany when their conversation turned to the health benefits which studies attribute to the drink. During the fermentation process of making wine, by-products are left over which are often just discarded as waste and the friends reasoned that since these by-products contain the goodness of wine in an even more concentrated form, and without the alcohol, shouldn't it be more often used and consumed by humans?

One of the friends was Bernd Diehl, the 48-year-old co-owner of a German chemical analysis company called Spectral Service. He proposed his company develop a method to turn the by-products into a powder preserving as many of the natural, healthy properties of wine as possible - the proteins, B vitamins, minerals and polyphenols, which are thought to prevent heart or circulation diseases, inflammation and thrombosis.

As a relatively small company, Spectral decided to partner with the larger Technologie-Transfer-Zentrum (TTZ), German specialists in product development, and the pair successfully applied to carry out their research as a EUREKA project. As well as developing wine powder, the partners also wanted to test their powders in different kinds of products in both food and drink, as well as in make-up. Here Spanish natural cosmetics company Alfaverde Productos Naturales was keen to help.

"We didn't just want to extract the nutrients from red wine and press them into pills," says ProVino's project leader Gabriele Randel. "We worked from the principle that if omega-3-fatty acids are good for you, it's better to eat fish than to swallow a -supplement. By adding red wine powder to products we also wanted to keep some of the taste and colour of red wine."

So the partners' two-year research programme began. Diehl and Randel drove up and down Germany, collecting wine material from vineyards in the Mosel, the Rheinland-Pfalz , t
'/>"/>

Contact: Dr. Gabriele Randele
randel@spectralservice.de
49-223-696-9470
EUREKA
Source:Eurekalert

Page: 1 2 3


Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 19th 2009 - Bacteria possess an ingenious mechani... blocks of the cell. This is the new finding of a ...VIB, a life sciences research institute in Flander...ussel. The scientists made this discovery by modif...hia coli . By means of this model organism, they h...
(Date:11/20/2009)...In a new study, researchers report that a class of... helpful, or harmful, effect on the heart, dependi...ch appears in the journal Circulation Research , ...a- and beta-receptors on the heart muscle offer th...at target only the beta-receptors can actually und...
(Date:11/19/2009)...tant crop in many countries of the world. It is wi...industrial materials. It also is considered an exe...lecular evolution, and genome architecture. The au...llection used the first description of the B73 mai...stions in genetics and plant biology. The ten pape...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Carvedilol shown to have unique characteristics among beta blockers 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Dr Julian Whitaker Featured on Searchjointpain com 50694 1Dr Julian Whitaker Featured on Searchjointpain com 50694 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 54 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 14 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 24 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 34 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 44 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 54 out of 5 CA Voters Demand Health Insurer 22Code of Conduct 22 50690 6
...n the Department of Biological Sciences have unrav...nary process in the human genome. Specific DNA seq...tate for long periods of time may not be simply ly...se elements have played a crucial role in human ev...ogeny copies, giving rise to the most abundant fam...
...arum uses different pathways to invade red blood ...cating efforts to create effective vaccines agains...Alan F. Cowman, an international research scholar ...tified a gene that the parasite uses to switch bac...ers from the Scripps Research Institute in La Joll...
... sub-Saharan Africa almost disappeared in the late...r trypanosomiasis, largely succumbed to heroic pub...villages. But in the past several decades, because...s has come back to ravage parts of Angola, the Dem... countries. In some regions, the tsetse fly-borne ...
Other Biology News:Scientists track stealth DNA elements in primate evolution 2Scientists track stealth DNA elements in primate evolution 3Gene expands malaria's invasion options 2Gene expands malaria's invasion options 3Compound might defeat African sleeping sickness, clinical trial beginning this month 2Compound might defeat African sleeping sickness, clinical trial beginning this month 3Compound might defeat African sleeping sickness, clinical trial beginning this month 4
(Date:11/19/2009).../ -- Danish Prince Joachim inaugurated the DONG En...dborg, Denmark, on Wednesday, November 18. The fac...generation ethanol demonstration biorefineries. Ge...,s innovative process for converting straw to fuel...o market with commercial enzymes for converting ce...
(Date:11/19/2009)...wire-FirstCall/ -- Spherix Incorporated (Nasdaq: ... therapy, and a provider of technical and regulato...hnology and pharmaceutical companies, today announ...reholders. ,, At the meeting, shareholders of S...ollowing members to the Board of Directors: ,, ...
(Date:11/19/2009)...e Synthesis Companies Form International Gene Synt...es in Risk Reduction ,Five Member Companies Repr...ity , (PRWEB) November 19...ynthesis companies today announced agreement that ...mote biosecurity in the gene synthesis industry. ...
(Date:11/18/2009)...to find explosive materials and persons who have b...e National Institute of Standards and Technology (...d Security, has developed a new certified referenc..., Trace Particulate Explosives. Compatible with fi...helpful in calibrating, testing and developing sta...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2
... Pharmaceuticals, Inc., a,vertically integrated cG...ay that it has appointed Diana Wood as Vice Presid...sible for all business development,functions, incl...,activities. Ms. Wood is a senior executive with e...and strategic planning, product development and,ge...
...le Biologics, a private,full-service pharmaceutica...t has entered into an agreement with Chiltern Inte...lence/safety reporting and medical information,ser...dent & CEO of Pinnacle Biologics stated, "The,comp...ificant step in the,process of offering a full ran...
...gy to electronics, photonics and renewable energy ... August 10 to 14, 2009 at McMaster University in H...will also be presented in conjunction with the eve...and Summer School (NGC2009) and the 14th Canadian ...l bring together two well-established conference s...
Other Biology Technology:Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development 2Pinnacle Biologics Announces Contract With Chiltern 2Joint nanotechnology forum to focus on electronics, photonics, renewable energy 2
Anti-FAK, phospho (Tyr576 / Tyr577) Antibody, Unconjugated from Cell Signaling Technology
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Rabbit Anti-ZFP200 Polyclonal Antibody, Unconjugated from Abcam
Anti-Human Ig Lambda-chain Monoclonal Antibody, Unconjugated, Clone ICO-16 from Cell Sciences
Biology Products: